Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
Introduction: A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, OPPs can work t...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association of Psychiatric Pharmacists
2022-04-01
|
| Series: | Mental Health Clinician |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2022.04.057 |
| _version_ | 1827576855340777472 |
|---|---|
| author | Richard J. Silvia, PharmD, BCPP Kelly C. Lee, PharmD, MAS, BCPP Gregory H. Payne, MBA Jessica Ho, PharmD, BCPS, BCPP Carla Cobb, PharmD, BCPP Elayne D. Ansara, PharmD, BCPS, BCPP Clint A. Ross, PharmD, BCPP |
| author_facet | Richard J. Silvia, PharmD, BCPP Kelly C. Lee, PharmD, MAS, BCPP Gregory H. Payne, MBA Jessica Ho, PharmD, BCPS, BCPP Carla Cobb, PharmD, BCPP Elayne D. Ansara, PharmD, BCPS, BCPP Clint A. Ross, PharmD, BCPP |
| author_sort | Richard J. Silvia, PharmD, BCPP |
| collection | DOAJ |
| description | Introduction: A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, OPPs can work toward consistent, effective patient care. This project aimed to develop attribute statements for a best practice model for OPPs providing direct patient care.
Methods: Board Certified Psychiatric Pharmacists and American Association of Psychiatric Pharmacists (AAPP) members were questioned using a 5-phase (P1-P5) survey and summit approach. The phases were: P1, broad ideation survey; P2, 10-person summit to develop draft statements; P3, survey of the draft statements for acceptance; P4, summit to resolve review feedback; and P5, survey of AAPP membership to confirm the finalized statements.
Results: P1 survey results generated a list of 143 possible attributes that informed the P2 summit, which were refined to 28 statements. P3 survey results confirmed at least 70% agreement with each statement. The P4 summit evaluated all P3 survey results and made significant modifications to 4 statements. Informal feedback was sought with other stakeholders, and supporting narratives and references were developed to provide clarity regarding the intent of each statement. Finalized statements and supporting narratives were confirmed in the P5 survey.
Discussion: The 28 attribute statements were developed over 18 months by gathering input and consensus through multiple modalities, including 3 surveys, 2 summit meetings, and numerous informal feedback requests. The agreement on the attribute statements was consistently high across all phases. The final attribute statements are presented elsewhere in this issue. |
| first_indexed | 2024-03-08T21:19:25Z |
| format | Article |
| id | doaj.art-80b1c702d5ae402bba5788baf3bef23b |
| institution | Directory Open Access Journal |
| issn | 2168-9709 |
| language | English |
| last_indexed | 2024-03-08T21:19:25Z |
| publishDate | 2022-04-01 |
| publisher | American Association of Psychiatric Pharmacists |
| record_format | Article |
| series | Mental Health Clinician |
| spelling | doaj.art-80b1c702d5ae402bba5788baf3bef23b2023-12-21T11:50:57ZengAmerican Association of Psychiatric PharmacistsMental Health Clinician2168-97092022-04-01122576410.9740/mhc.2022.04.057i2168-9709-12-02-057Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statementsRichard J. Silvia, PharmD, BCPP0https://orcid.org/0000-0003-3089-4490Kelly C. Lee, PharmD, MAS, BCPP1https://orcid.org/0000-0002-1674-4210Gregory H. Payne, MBA2https://orcid.org/0000-0002-8592-7280Jessica Ho, PharmD, BCPS, BCPP3https://orcid.org/0000-0002-4434-6981Carla Cobb, PharmD, BCPP4https://orcid.org/0000-0002-0827-5485Elayne D. Ansara, PharmD, BCPS, BCPP5https://orcid.org/0000-0001-9835-0305Clint A. Ross, PharmD, BCPP6https://orcid.org/0000-0002-2684-782X1 Professor of Pharmacy Practice, School of Pharmacy-Boston, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts2 Professor of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California3 Director of Strategic Initiatives, American Association of Psychiatric Pharmacists, Lincoln, Nebraska4 Psychiatric Clinical Pharmacy Specialist, Kaiser Permanente of the Mid-Atlantic States, Burke, Virginia5 Psychiatric Pharmacist, Capita Consulting, Billings, Montana6 Clinical Pharmacy Practitioner, Mental Health, Veteran Health Indiana, Indianapolis, Indiana7 Psychiatric Pharmacy Coordinator, MUSC Health, Charleston, South CarolinaIntroduction: A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, OPPs can work toward consistent, effective patient care. This project aimed to develop attribute statements for a best practice model for OPPs providing direct patient care. Methods: Board Certified Psychiatric Pharmacists and American Association of Psychiatric Pharmacists (AAPP) members were questioned using a 5-phase (P1-P5) survey and summit approach. The phases were: P1, broad ideation survey; P2, 10-person summit to develop draft statements; P3, survey of the draft statements for acceptance; P4, summit to resolve review feedback; and P5, survey of AAPP membership to confirm the finalized statements. Results: P1 survey results generated a list of 143 possible attributes that informed the P2 summit, which were refined to 28 statements. P3 survey results confirmed at least 70% agreement with each statement. The P4 summit evaluated all P3 survey results and made significant modifications to 4 statements. Informal feedback was sought with other stakeholders, and supporting narratives and references were developed to provide clarity regarding the intent of each statement. Finalized statements and supporting narratives were confirmed in the P5 survey. Discussion: The 28 attribute statements were developed over 18 months by gathering input and consensus through multiple modalities, including 3 surveys, 2 summit meetings, and numerous informal feedback requests. The agreement on the attribute statements was consistently high across all phases. The final attribute statements are presented elsewhere in this issue.https://theijpt.org/doi/pdf/10.9740/mhc.2022.04.057outpatientpsychiatric pharmacybest practiceattributesconsensus |
| spellingShingle | Richard J. Silvia, PharmD, BCPP Kelly C. Lee, PharmD, MAS, BCPP Gregory H. Payne, MBA Jessica Ho, PharmD, BCPS, BCPP Carla Cobb, PharmD, BCPP Elayne D. Ansara, PharmD, BCPS, BCPP Clint A. Ross, PharmD, BCPP Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements Mental Health Clinician outpatient psychiatric pharmacy best practice attributes consensus |
| title | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
| title_full | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
| title_fullStr | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
| title_full_unstemmed | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
| title_short | Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements |
| title_sort | best practice model for outpatient psychiatric pharmacy practice part 1 development of initial attribute statements |
| topic | outpatient psychiatric pharmacy best practice attributes consensus |
| url | https://theijpt.org/doi/pdf/10.9740/mhc.2022.04.057 |
| work_keys_str_mv | AT richardjsilviapharmdbcpp bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT kellycleepharmdmasbcpp bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT gregoryhpaynemba bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT jessicahopharmdbcpsbcpp bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT carlacobbpharmdbcpp bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT elaynedansarapharmdbcpsbcpp bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements AT clintarosspharmdbcpp bestpracticemodelforoutpatientpsychiatricpharmacypracticepart1developmentofinitialattributestatements |